Product Information

ETODOLAC ER 500 MG TABLET is a generic product labeled by Taro Pharmaceuticals U.S.A. Inc., priced at $0.7061 per EA under NDC 51672405201. Its NADAC has been published 677 times since Nov 28, 2013.

FDA first approved this application on Mar 13, 2003. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ETODOLAC ER 500 MG TABLET

Etodolac
$0.7061per EA

Strength

500 mg/1

NDC

51672405201

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

ETODOLAC

Approval Type

Generic (ANDA)

FDA Application

ANDA076174

FDA Approved

3/13/2003

TE Code

AB

On Market Since

3/13/2003

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for ETODOLAC ER 500 MG TABLET has been published 677 times since Nov 28, 2013, and over the history we have for it it has declined 63.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.7061 per EA
All-time high$2.4199 (Apr 16, 2014)
All-time low$0.7061 (Oct 21, 2026)
52-week high$0.9353
52-week low$0.7061
Median price$1.4866
Average price$1.5827
Largest weekly change-30.7% (Jul 19, 2023)
Weeks tracked677
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

-1.6%

3M

-3.2%

6M

-15.3%

1Y

-25.8%

3Y

-25.5%

5Y

-50.3%

All

-63.2%

Generic Alternatives

The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 58% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ETODOLAC ER 500 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ETODOLAC ER 500 MG TABLET, manufactured by Taro Pharmaceuticals U.S.A. Inc., is $0.7061 per EA (NDC 51672405201), effective Nov 11, 2026.

How has the price of ETODOLAC ER 500 MG TABLET changed over time?

Over the history we have for it, the NADAC for ETODOLAC ER 500 MG TABLET has declined 63.2%. It has been tracked across 677 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for ETODOLAC ER 500 MG TABLET?

Since Nov 28, 2013, the NADAC for ETODOLAC ER 500 MG TABLET has ranged from a low of $0.7061 (Oct 21, 2026) to a high of $2.4199 (Apr 16, 2014), with a median of $1.4866 per EA.

Are there cheaper alternatives to ETODOLAC ER 500 MG TABLET?

Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ETODOLAC 500 MG TABLET, is $0.2933 per EA — about 58% below ETODOLAC ER 500 MG TABLET.

Who manufactures ETODOLAC ER 500 MG TABLET?

ETODOLAC ER 500 MG TABLET (NDC 51672405201) is labeled by Taro Pharmaceuticals U.S.A. Inc., and CMS classifies it as a generic product.